CVS pushing into kidney dialysis with Dean Kamen’s help
Click here to view this article at the source publication 
CVS Health Corp. is beginning human trials of a new home dialysis machine that could shake up the $35 billion market for end-stage kidney care and could create a new business for the drugstore chain.
The company plans to offer a device designed by a Manchester firm founded by Dean Kamen, the inventor of the two-wheeled Segway personal transporter. The goal is to make the complicated process of dialysis, which cleans toxins from a patient’s blood, easier and safer to do at home. If successful, CVS could threaten the two companies that dominate the market for outpatient dialysis clinics, which most users visit three times a week.